These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9545712)

  • 1. [Structure and activities of drug committees in Germany. Results of a survey of 143 hospitals. Pharmaco-economic Study Group and Rational Drug Therapy of the German Society of Clinical Pharmacology and Therapy].
    Harder S; Thürmann P; Steioff A
    Med Klin (Munich); 1998 Feb; 93(2):119-24. PubMed ID: 9545712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and activities of hospital drug committees in Germany.
    Thürmann PA; Harder S; Steioff A
    Eur J Clin Pharmacol; 1997; 52(6):429-35. PubMed ID: 9342577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation and monitoring of decisions by pharmacy and therapeutics committees in South African public sector hospitals.
    Mashaba TP; Matlala M; Godman B; Meyer JC
    Expert Rev Clin Pharmacol; 2019 Feb; 12(2):159-168. PubMed ID: 30407089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
    Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
    Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and procedures of the pharmacy and therapeutic committees in Spanish hospitals.
    Puigventós F; Santos-Ramos B; Ortega A; Durán-García E
    Pharm World Sci; 2010 Dec; 32(6):767-75. PubMed ID: 20820918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug and Therapeutics (D & T) committees in Dutch hospitals: a nation-wide survey of structure, activities, and drug selection procedures.
    Fijn R; Brouwers JR; Knaap RJ; De Jong-Van Den Berg LT
    Br J Clin Pharmacol; 1999 Aug; 48(2):239-46. PubMed ID: 10417503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Literature review on the structure and operation of Pharmacy and Therapeutics Committees.
    Durán-García E; Santos-Ramos B; Puigventos-Latorre F; Ortega A
    Int J Clin Pharm; 2011 Jun; 33(3):475-83. PubMed ID: 21416393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
    Mittmann N; Knowles S
    Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications.
    Matlala M; Gous AG; Godman B; Meyer JC
    Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1273-1280. PubMed ID: 28776442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug and therapeutics committees in Danish hospitals: a survey of organization, activities and drug selection procedures.
    Plet HT; Hallas J; Nielsen GS; Kjeldsen LJ
    Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):264-9. PubMed ID: 23107106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-use evaluation programs in short-term-care general hospitals.
    Terry AK; Draugalis JR; Bootman JL
    Am J Hosp Pharm; 1993 May; 50(5):940-4. PubMed ID: 8506873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organization and operation of P & T Committees in the state of Florida: a survey.
    Hatton RC; Doering PL
    Hosp Formul; 1990 Sep; 25(9):983-6, 988-9. PubMed ID: 10106259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug approval processes in Australian Paediatric Hospitals.
    Sinha YK; Craig JC; Barclay P; Taitz J; South M; Coulthard K; Pearson C; Erickson S; Brien JE
    Arch Dis Child; 2010 Sep; 95(9):739-44. PubMed ID: 20584852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process.
    Shalansky SJ; Virk R; Ackman M; Jackevicius C; Kertland H; Tsuyuki R; Humphries K;
    Can J Cardiol; 2003 Feb; 19(2):173-9. PubMed ID: 12601443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug committees in Denmark. Status and future challenges].
    Rabøl R; Kampmann JP; Christensen HR
    Ugeskr Laeger; 2004 Aug; 166(35):2988-91. PubMed ID: 15387009
    [No Abstract]   [Full Text] [Related]  

  • 16. A survey of selective administration procedures in formulary maintenance.
    Quigley MA; Brown WM
    Hosp Pharm; 1981 Jul; 15(7):371-4, 378-80. PubMed ID: 10252001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug and Therapeutics Committees in Australia: expected and actual performance.
    Weekes LM; Brooks C
    Br J Clin Pharmacol; 1996 Nov; 42(5):551-7. PubMed ID: 8951185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in activity and results from drug assessments by pharmacy and therapeutics committees in Spanish hospitals.
    Puigventós Latorre F; Santos-Ramos B; Ortega Eslava A; Durán-García ME;
    Farm Hosp; 2011; 35(6):305-14. PubMed ID: 21497125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug and therapeutics committees: the relationships among structure, function, and effectiveness.
    Plumridge RJ; Stoelwinder JU; Rucker TD
    Hosp Pharm; 1993 Jun; 28(6):492-3, 496-8, 508. PubMed ID: 10126453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-tier drugs assessment in a decentralised health care system. The Italian case-study.
    Jommi C; Costa E; Michelon A; Pisacane M; Scroccaro G
    Health Policy; 2013 Oct; 112(3):241-7. PubMed ID: 23850166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.